The NIH Roadmap Epigenomics Mapping Consortium (Englisch)
- Neue Suche nach: Bernstein, Bradley E
- Neue Suche nach: Bernstein, Bradley E
- Neue Suche nach: Stamatoyannopoulos, John A
- Neue Suche nach: Costello, Joseph F
- Neue Suche nach: Ren, Bing
- Neue Suche nach: Milosavljevic, Aleksandar
- Neue Suche nach: Meissner, Alexander
- Neue Suche nach: Kellis, Manolis
- Neue Suche nach: Marra, Marco A
- Neue Suche nach: Beaudet, Arthur L
- Neue Suche nach: Ecker, Joseph R
- Neue Suche nach: Farnham, Peggy J
- Neue Suche nach: Hirst, Martin
- Neue Suche nach: Lander, Eric S
- Neue Suche nach: Mikkelsen, Tarjei S
- Neue Suche nach: Thomson, James A
In:
Nature biotechnology
;
28
, 10
; 1045-1049
;
2010
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:The NIH Roadmap Epigenomics Mapping Consortium
-
Beteiligte:
-
Erschienen in:Nature biotechnology ; 28, 10 ; 1045-1049
-
Verlag:
- Neue Suche nach: Springer Nature
-
Erscheinungsort:New York, NY
-
Erscheinungsdatum:2010
-
ISSN:
-
ZDBID:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 58.30
- Weitere Informationen zu Basisklassifikation
-
Schlagwörter:
-
Klassifikation:
BKL: 58.30 Biotechnologie -
Datenquelle:
Inhaltsverzeichnis – Band 28, Ausgabe 10
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 987
-
Teetering on the brink| 2010
- 989
-
Geron trial resumes, but standards for stem cell trials remain elusiveStrauss, Stephen et al. | 2010
- 990
-
China's $2.4 billion splurgeJia, Hepeng et al. | 2010
- 991
-
US courts throw ES cell research into disarrayFox, Jeffrey L et al. | 2010
- 992
-
Sugar beets still in the gameLaursen, Lucas et al. | 2010
- 992
-
Roche backs Aileron's stapled peptidesSheridan, Cormac et al. | 2010
- 992
-
Drug user fees top $1 millionDeFrancesco, Laura et al. | 2010
- 994
-
Anti-anemics price hikeDorey, Emma et al. | 2010
- 994
-
Genzyme resumes shipping as Sanofi-aventis hoversRatner, Mark et al. | 2010
- 994
-
Life swallows Ion TorrentEisenstein, Michael et al. | 2010
- 995
-
Cancer research fund launches biologics pilot plantSubbaraman, Nidhi et al. | 2010
- 996
-
Monsanto relaxes restrictions on sharing seeds for researchWaltz, Emily et al. | 2010
- 996
-
Hungary eyes biotech jobsElvidge, Suzanne et al. | 2010
- 996
-
Wellcome partners with IndiaJayaraman, Killugudi et al. | 2010
- 997
-
Newsmaker: Constellation PharmaceuticalsOsborne, Randy et al. | 2010
- 998
-
Drug pipeline: Q310Peng, Wayne et al. | 2010
- 999
-
Turning the tide in lung cancerAllison, Malorye et al. | 2010
- 1003
-
At the heart of genetic testingStrauss, Stephen et al. | 2010
- 1010
-
Safe and effective synthetic biologyLaVan, David A et al. | 2010
- 1012
-
The regulatory bottleneck for biotech specialty cropsMiller, Jamie K et al. | 2010
- 1015
-
ProHits: integrated software for mass spectrometry–based interaction proteomicsLiu, Guomin et al. | 2010
- 1017
-
More sizzle than fizzleLee, Kevin et al. | 2010
- 1018
-
The path less costlyHuggett, Brady et al. | 2010
- 1019
-
Faculty and employee ownership of inventions in AustraliaMcBratney, Amanda et al. | 2010
- 1023
-
Recent patent applications in gene synthesis| 2010
- 1025
-
Timing is everything in the human embryoKiessling, Ann A et al. | 2010
- 1026
-
Taking the measure of the methylomeBeck, Stephan et al. | 2010
- 1028
-
Tracing cancer networks with phosphoproteomicsSolit, David B et al. | 2010
- 1030
-
Research highlights| 2010
- 1031
-
Making a mark| 2010
- 1033
-
Linking cell signaling and the epigenetic machineryMohammad, Helai P et al. | 2010
- 1039
-
Tackling the epigenome: challenges and opportunities for collaborationSatterlee, John S et al. | 2010
- 1045
-
The NIH Roadmap Epigenomics Mapping ConsortiumBernstein, Bradley E et al. | 2010
- 1049
-
Epigenomics reveals a functional genome anatomy and a new approach to common diseaseFeinberg, Andrew P et al. | 2010
- 1053
-
Putting epigenome comparison into practiceMilosavljevic, Aleksandar et al. | 2010
- 1057
-
Epigenetic modifications and human diseasePortela, Anna et al. | 2010
- 1069
-
Epigenetic modifications as therapeutic targetsKelly, Theresa K et al. | 2010
- 1079
-
Epigenetic modifications in pluripotent and differentiated cellsMeissner, Alexander et al. | 2010
- 1089
-
Genomics tools for unraveling chromosome architecturevan Steensel, Bas et al. | 2010
- 1097
-
Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modificationsHarris, R Alan et al. | 2010
- 1106
-
Quantitative comparison of genome-wide DNA methylation mapping technologiesBock, Christoph et al. | 2010
- 1115
-
Non-invasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stageWong, Connie C et al. | 2010
- 1123
-
Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cellsHolst, Jeff et al. | 2010
- 1129
-
Food firms test fry Pioneer's trans fat-free soybean oilWaltz, Emily et al. | 2010
- 1129
-
Pluripotent patents make prime time: an analysis of the emerging landscapeSimon, Brenda M et al. | 2010
- 1129
-
Glyphosate resistance threatens Roundup hegemonyWaltz, Emily et al. | 2010
- 1129
-
Pfizer explores rare disease pathShaffer, Catherine et al. | 2010
- 1129
-
Public biotech 2009—the numbersHuggett, Brady et al. | 2010
- 1131
-
Portfolio managing for scientistsSable, David et al. | 2010
- 1132
-
People| 2010